Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puri Fortes

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta|May 31, 2011
Adenovirus and miRNAsElena Carnero, James D Sutherland, Puri Fortes
Frontiers in Immunology|May 14, 2023
Editorial: Long non-coding RNAs in viral infections and immunitySaikat Boliar, Laura Prats-Mari, Puri Fortes
Frontiers in Immunology|January 27, 2015
Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor TetherinMarina Barriocanal, Elena Carnero, Victor Segura, et al.
International Journal of Molecular Sciences|July 27, 2013
Long non-coding RNAs in haematological malignanciesAndoni Garitano-Trojaola, Xabier Agirre, Felipe Prósper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Factors influencing the production of recombinant SV40 vectorsMaria Vera, Jesus Prieto, David S Strayer, et al.
International Journal of Molecular Sciences|September 9, 2020
LncRNAs in the Type I Interferon Antiviral ResponseBeatriz Suarez, Laura Prats-Mari, Juan P Unfried, et al.
Plos One|September 23, 2016
Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in RatsLuciano Sobrevals, Mónica Enguita, Jorge Quiroga, et al.
Journal of Virology|January 18, 2006
Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus productionOscar Aparicio, Nerea Razquin, Mikel Zaratiegui, et al.
Antiviral Research|April 18, 2012
Design of modified U1i molecules against HIV-1 RNAStefanie A Knoepfel, Amaya Abad, Xabi Abad, et al.
Human Vaccines & Immunotherapeutics|February 12, 2024
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapiesBelen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta|May 31, 2011
Adenovirus and miRNAsElena Carnero, James D Sutherland, Puri Fortes
Frontiers in Immunology|May 14, 2023
Editorial: Long non-coding RNAs in viral infections and immunitySaikat Boliar, Laura Prats-Mari, Puri Fortes
Frontiers in Immunology|January 27, 2015
Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor TetherinMarina Barriocanal, Elena Carnero, Victor Segura, et al.
International Journal of Molecular Sciences|July 27, 2013
Long non-coding RNAs in haematological malignanciesAndoni Garitano-Trojaola, Xabier Agirre, Felipe Prósper, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
Factors influencing the production of recombinant SV40 vectorsMaria Vera, Jesus Prieto, David S Strayer, et al.
International Journal of Molecular Sciences|September 9, 2020
LncRNAs in the Type I Interferon Antiviral ResponseBeatriz Suarez, Laura Prats-Mari, Juan P Unfried, et al.
Plos One|September 23, 2016
Insulin-Like Growth Factor I (IGF-I) Expressed from an AAV1 Vector Leads to a Complete Reversion of Liver Cirrhosis in RatsLuciano Sobrevals, Mónica Enguita, Jorge Quiroga, et al.
Journal of Virology|January 18, 2006
Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus productionOscar Aparicio, Nerea Razquin, Mikel Zaratiegui, et al.
Antiviral Research|April 18, 2012
Design of modified U1i molecules against HIV-1 RNAStefanie A Knoepfel, Amaya Abad, Xabi Abad, et al.
Human Vaccines & Immunotherapeutics|February 12, 2024
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapiesBelen Aparicio, Patrick Theunissen, Sandra Hervas-Stubbs, et al.
Pageof 7